282 related articles for article (PubMed ID: 38426560)
21. Identifying potential germline variants from sequencing hematopoietic malignancies.
Kraft IL; Godley LA
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):219-227. PubMed ID: 33275754
[TBL] [Abstract][Full Text] [Related]
22. Identifying potential germline variants from sequencing hematopoietic malignancies.
Kraft IL; Godley LA
Blood; 2020 Nov; 136(22):2498-2506. PubMed ID: 33236764
[TBL] [Abstract][Full Text] [Related]
23. Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia.
Douglas SPM; Lahtinen AK; Koski JR; Leimi L; Keränen MAI; Koskenvuo M; Heckman CA; Jahnukainen K; Pitkänen E; Wartiovaara-Kautto U; Kilpivaara O
Sci Rep; 2022 Jun; 12(1):10670. PubMed ID: 35739278
[TBL] [Abstract][Full Text] [Related]
24. Hereditary Predispositions to Myelodysplastic Syndrome.
Bannon SA; DiNardo CD
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27248996
[TBL] [Abstract][Full Text] [Related]
25. Genetic predisposition to MDS: diagnosis and management.
Furutani E; Shimamura A
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):110-119. PubMed ID: 31808839
[TBL] [Abstract][Full Text] [Related]
26. [Genetic predisposition to myelodysplastic syndrome/leukemia].
Hirabayashi S
Rinsho Ketsueki; 2021; 62(8):1029-1037. PubMed ID: 34497189
[TBL] [Abstract][Full Text] [Related]
27. Beyond Pathogenic
Förster A; Decker M; Schlegelberger B; Ripperger T
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884491
[TBL] [Abstract][Full Text] [Related]
28. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Tawana K; Drazer MW; Churpek JE
Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
[TBL] [Abstract][Full Text] [Related]
29. Clonal dynamics of donor-derived myelodysplastic syndrome after unrelated hematopoietic cell transplantation for high-risk pediatric B-lymphoblastic leukemia.
Schwartz JR; Walsh MP; Ma J; Lamprecht T; Wang S; Wu G; Raimondi S; Triplett BM; Klco JM
Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 29891567
[TBL] [Abstract][Full Text] [Related]
30. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
Elife; 2023 Jan; 12():. PubMed ID: 36629404
[TBL] [Abstract][Full Text] [Related]
31. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
Ye B; Sheng Y; Zhang M; Hu Y; Huang H
Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
[TBL] [Abstract][Full Text] [Related]
32. Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition.
Gao J; Chen Y; Sukhanova M
Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054439
[TBL] [Abstract][Full Text] [Related]
33. What Clonal Hematopoiesis Can Teach Us About MDS.
Chan ICC; Wiley BJ; Bolton KL
Front Oncol; 2022; 12():794021. PubMed ID: 35211401
[TBL] [Abstract][Full Text] [Related]
34. Genetic predisposition to MDS: clinical features and clonal evolution.
Kennedy AL; Shimamura A
Blood; 2019 Mar; 133(10):1071-1085. PubMed ID: 30670445
[TBL] [Abstract][Full Text] [Related]
35. Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies.
Godley LA
Front Oncol; 2023; 13():1084736. PubMed ID: 36793609
[TBL] [Abstract][Full Text] [Related]
36. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
37. Molecular alterations governing predisposition to myelodysplastic syndromes: Insights from Shwachman-Diamond syndrome.
Shimamura A
Best Pract Res Clin Haematol; 2021 Mar; 34(1):101252. PubMed ID: 33762106
[TBL] [Abstract][Full Text] [Related]
38. Germline ETV6 mutations and predisposition to hematological malignancies.
Feurstein S; Godley LA
Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
[TBL] [Abstract][Full Text] [Related]
39. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
